The North America Chronic Disease Management Market would witness market growth of 11.0% CAGR during the forecast period (2022-2028).
Motivational interviewing and coaching are two well-known methodologies. Cost savings and better outcomes have both been linked to more patient activation and participation. But, it is still unclear whether such a scheme can genuinely lessen the financial burden of rising medical costs for those with chronic conditions.
Since some studies of disease management programmes have examined the influence on health care costs, the body of evidence is fairly thin. Few studies effectively characterize programme components in order to identify which components have an impact on costs. Whereas it is frequently believed that preventative interventions lower net health care costs, this is not always the case.
The Healthcare Navigator, a programme for the treatment of chronic diseases, was developed by the American Health Data Institute (AHDI) in 2002. The Healthcare Navigator programme is a part of an integrated approach to controlling health care utilization, and its goal is to assist client firms in lowering their health care expenditures by enhancing both self-care and the receiving of necessary preventive treatment from formal health care providers.
The US market dominated the North America Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,637.9 million by 2028.The Canada market is poised to grow at a CAGR of 13.5% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 12.5% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Chronic Disease Management Market is Estimated to reach $9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
By End User
- Healthcare Providers
- Healthcare Payers
- Others
By Disease Type
- Diabetes
- Cardiovascular diseases
- Asthma
- Chronic obstructive pulmonary disorders
- Cancer
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Infosys Limited
- ExlService Holdings, Inc.
- Health Catalyst, Inc.
- AllScripts Healthcare Solutions, Inc.
- Koninklijke Philips N.V.
- Cognizant Technology Solutions Corporation
- Casenet, LLC
- Cedar Gate Technologies
- Clinical Excellence, Inc.
- Altruista Health, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Chronic Disease Management Market, by Type
1.4.2 North America Chronic Disease Management Market, by End User
1.4.3 North America Chronic Disease Management Market, by Disease Type
1.4.4 North America Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. North America Chronic Disease Management Market by Type
4.1 North America Solutions Market by Country
4.2 North America Services Market by Country
Chapter 5. North America Chronic Disease Management Market by End User
5.1 North America Healthcare Providers Market by Country
5.2 North America Healthcare Payers Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Chronic Disease Management Market by Disease Type
6.1 North America Diabetes Market by Country
6.2 North America Cardiovascular diseases Market by Country
6.3 North America Asthma Market by Country
6.4 North America Chronic obstructive pulmonary disorders Market by Country
6.5 North America Cancer Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Chronic Disease Management Market by Country
7.1 US Chronic Disease Management Market
7.1.1 US Chronic Disease Management Market by Type
7.1.2 US Chronic Disease Management Market by End User
7.1.3 US Chronic Disease Management Market by Disease Type
7.2 Canada Chronic Disease Management Market
7.2.1 Canada Chronic Disease Management Market by Type
7.2.2 Canada Chronic Disease Management Market by End User
7.2.3 Canada Chronic Disease Management Market by Disease Type
7.3 Mexico Chronic Disease Management Market
7.3.1 Mexico Chronic Disease Management Market by Type
7.3.2 Mexico Chronic Disease Management Market by End User
7.3.3 Mexico Chronic Disease Management Market by Disease Type
7.4 Rest of North America Chronic Disease Management Market
7.4.1 Rest of North America Chronic Disease Management Market by Type
7.4.2 Rest of North America Chronic Disease Management Market by End User
7.4.3 Rest of North America Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
TABLE 1 North America Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 2 North America Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Chronic Disease Management Market
TABLE 4 Product Launches And Product Expansions – Chronic Disease Management Market
TABLE 5 Acquisition and Mergers – Chronic Disease Management Market
TABLE 6 Approvals and Trials – Chronic Disease Management Market
TABLE 7 North America Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 8 North America Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 9 North America Solutions Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Solutions Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 14 North America Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 15 North America Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 22 North America Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 23 North America Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Asthma Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Asthma Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 37 US Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 38 US Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 39 US Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 40 US Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 41 US Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 42 US Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 43 US Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 44 US Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 45 Canada Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 46 Canada Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 47 Canada Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 48 Canada Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 49 Canada Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 50 Canada Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 51 Canada Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 52 Canada Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 53 Mexico Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 54 Mexico Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 55 Mexico Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 56 Mexico Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 57 Mexico Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 58 Mexico Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 59 Mexico Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 60 Mexico Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 61 Rest of North America Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 62 Rest of North America Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 63 Rest of North America Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 64 Rest of North America Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 65 Rest of North America Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 66 Rest of North America Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 67 Rest of North America Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 68 Rest of North America Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 69 Key Information – Infosys Limited
TABLE 70 Key Information – ExlService Holdings, Inc.
TABLE 71 Key Information – Health Catalyst, Inc.
TABLE 72 Key Information – AllScripts Healthcare Solutions, Inc.
TABLE 73 Key Information – Koninklijke Philips N.V.
TABLE 74 Key Information – Cognizant Technology Solutions Corporation
TABLE 75 Key Information – Casenet, LLC
TABLE 76 Key Information – Cedar Gate Technologies
TABLE 77 Key Information – Clinical Excellence, Inc.
TABLE 78 Key Information – Altruista Health, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
FIG 5 SWOT Analysis: Infosys Limited
FIG 6 Recent strategies and developments: Koninklijke Philips N.V.
FIG 7 Swot analysis: cognizant technology solutions corporation